75N95022F00001↗
Booz Allen Hamilton Inc received this contract from National Institutes of Health Nida, National Institutes of Health: -$18.5K obligated so far for health r&d services; health care services; basic research. Its period of performance ended 2023-09-16.
Key facts · data as of Oct 25, 2026
- Recipient
- Booz Allen Hamilton Inc
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nida (75N950)
- Obligated to date
- -$18.5K
- Potential value
- $8.92M
- Ends
- 2023-09-16
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N95022F00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N95022F00001_7529_75N95021D00023_7529
Booz Allen Hamilton Inc: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nida: what it buys
NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2021 - SEPTEMBER 16, 2022. N01DA-21-5588. TASK ORDER 75N95022F00001 (TO2).
What it is
- Product or service
- Health R&D Services; Health Care Services; Basic Research (PSC AN11)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- National Institutes of Health Nida (75N950)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75N95021D00023
- Solicitation
- 75N95022F00001
- Where the work is
- Fairfax, VA · district VA-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
3 subawards totaling $7.09M (708657209.0% of what was obligated), as Booz Allen Hamilton Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Infinity Biologix LLC | $6.11M | 2 | NJ | 2023-01-25 | 2023-09-15 |
| United States Drug Testing Laboratories, Inc. | $975.5K | 1 | IL | 2022-10-19 | 2022-10-19 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2023-01-25 | Infinity Biologix LLC | $4.90M | PROVIDE A BIOREPOSITORY AND PERFORM IN CLIA-CERTIFIED LABORATORIES, CERTAIN METABOLIC, HEMATOLOGIC, AND OTHER ASSAYS, AND CUTTING-EDGE, HIGH THROUGH-PUT GENOTYPING, SEQUENCING, AND GENE-EXPRESSION. |
| 2023-09-15 | Infinity Biologix LLC | $1.21M | PROVIDE A BIOREPOSITORY AND PERFORM IN CLIA-CERTIFIED LABORATORIES, CERTAIN METABOLIC, HEMATOLOGIC, AND OTHER ASSAYS, AND CUTTING-EDGE, HIGH THROUGH-PUT GENOTYPING, SEQUENCING, AND GENE-EXPRESSION. |
| 2022-10-19 | United States Drug Testing Laboratories, Inc. | $975.5K | TOXICOLOGY ANALYSIS OF BIOLOGICAL TISSUES AND FLUIDS |
Every action
1 action since 2026-05-14. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-14 | P00001 | Funding only | -$18.5K | FY26 UDO INITIATIVE. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2021 - SEPTEMBER 16, 2022. N01DA-21-5588. TASK ORDER 75N95022F00001 (TO2). |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗